Could a gentle zap to the brain ease Parkinson's symptoms?

NCT ID NCT07534397

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether a gentle, non-invasive brain stimulation technique called tDCS can improve verbal fluency, thinking, and motor control in people with Parkinson's disease. Twenty participants aged 50-90 with Parkinson's and a verbal fluency deficit will receive the stimulation. The goal is to see if this approach can help with everyday tasks like speaking and moving.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could point toward a non-invasive, drug-free way to ease cognitive and motor symptoms in Parkinson's disease.
What could go wrong
This is a very small, early-stage study (20 people) with no control group comparison yet. The effects may be small or not last, and tDCS may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Callier Clinical Center, The University of Texas at Dallas

    Richardson, Texas, 75080, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.